Drug Shortage Report for METHOTREXATE INJECTION USP

Last updated on 2018-04-20 History
Report ID 28847
Drug Identification Number 02182971
Brand name METHOTREXATE INJECTION USP
Common or Proper name Methotrexate
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) METHOTREXATE
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 1 x 20 mL
ATC code L01BA
ATC description ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-01-24
Estimated end date
Actual end date 2018-04-19
Shortage status Resolved
Updated date 2018-04-20
Company comments Please note that only 1 lot with an expiry date of 2/28/2018 remains available.
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2018-04-20 English Compare
v15 2018-04-19 French Compare
v14 2018-04-19 English Compare
v13 2018-03-14 French Compare
v12 2018-03-14 English Compare
v11 2018-01-16 English Compare
v10 2017-12-20 French Compare
v9 2017-12-20 English Compare
v8 2017-12-16 English Compare
v7 2017-12-12 French Compare
v6 2017-12-12 English Compare
v5 2017-11-10 French Compare
v4 2017-11-10 English Compare
v3 2017-11-10 French Compare
v2 2017-11-10 English Compare
v1 2017-11-10 English Compare